U
CBD Life Sciences Inc. CBDL
$0.0004 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 03/31/2023 03/31/2022 09/30/2021
Revenue 36.19% -32.69% 141.24% -81.57%
Total Other Revenue -- -- -- --
Total Revenue 36.19% -32.69% 141.24% -81.57%
Cost of Revenue 73.10% -36.68% 62.41% -78.70%
Gross Profit 4.12% -28.87% 359.62% -84.88%
SG&A Expenses 72.66% -86.07% -83.28% 788.58%
Depreciation & Amortization -- -- -- --
Other Operating Expenses -- -- -61.64% --
Total Operating Expenses 72.78% -83.32% -81.28% 528.58%
Operating Income -122.98% 91.71% 83.75% -1,316.56%
Income Before Tax -122.98% 91.71% 83.75% 2.59%
Income Tax Expenses -- -- -- --
Earnings from Continuing Operations -122.98% 91.71% 83.75% 2.59%
Earnings from Discontinued Operations -- -- -- --
Extraordinary Item & Accounting Change -- -- -- --
Minority Interest in Earnings -- -- -- --
Net Income -122.98% 91.71% 83.75% 2.59%
EBIT -122.98% 91.71% 83.75% -1,316.56%
EBITDA -578.00% 98.16% -- --
EPS Basic -100.00% 90.48% 95.07% 97.15%
Normalized Basic EPS -100.00% 92.31% 95.11% 67.86%
EPS Diluted -100.00% 90.48% 95.07% 97.15%
Normalized Diluted EPS -100.00% 92.31% 95.11% 67.86%
Average Basic Shares Outstanding 0.00% 0.00% 231.01% 3,310.03%
Average Diluted Shares Outstanding 0.00% 0.00% 231.01% 3,310.03%
Dividend Per Share -- -- -- --
Payout Ratio -- -- -- --
Weiss Ratings